Puma Biotechnology (PBYI) Prix de l'Action, Cotation, Actualités et Historique | Benzinga

Puma Biotechnology Inc (PBYI) Prix de l'Action, Cotation, Actualités et Historique

PBYINASDAQ

Trade with Public

Trade with Public

$10.18

0.353.56%

Dern. MÀJ: Oct 19, 1:32 PM

$10.55

0.727.32%

AperçuActualités Prévisions de résultats Événements Objectifs de cours Données financières Sentiment Actionnariat Comparer Options Rapport sur les stocks

© 2026 Benzinga | All Rights Reserved

Statistiques Clés

Ouverture

$9.85

Clôture

-

Volume / Moy.

185.11K / 318.99K

Fourchette Journalière

$9.74 - $10.18

Plage 52 Sem.

4.58 - 10.72

Capitalisation Boursière

$525.49M

Ratio P/E

19.27

Rendement des Dividendes

-

Échange

NASDAQ

RSI

70

Intérêt à Découvert

9.68%

Jours pour Couvrir

14.02

Actualités Récentes de Puma Biotechnology Inc

Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute

A Delaware jury ordered AstraZeneca to pay Pfizer $107.5 million, ruling that AstraZeneca's lung cancer drug Tagrisso infringed on Pfizer's patents related to cancer treatment.

Vandana Singh

Puma Biotechnology's Q1 Earnings and Revenues Beat

Puma Biotechnology, Inc. (NASDAQ: PBYI) reported first-quarter 2024 adjusted loss of 5 cents per share, which was narrower than the Zacks Consensus Estimate of a loss of 16 cents. In the year-ago quarter, the company had reported adjusted earnings of 9 cents.

Zacks

Why Nanobiotix Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

Gainers Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) shares surged 39.3% to $0.6621 in pre-market trading after gaining around 14% on Wednesday.

Lisa Levin

Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront payment of $90 million.

Lisa Levin

Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers ObsEva SA (NASDAQ: OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.

Lisa Levin

Données financières

Trimestriel

Annuel

Nom

Revenu Changement
Brut Changement
EBITDA Changement
EBIT Changement
Bénéfices Changement

Flux de Trésorerie

Flux de Trésorerie Opérationnel (TTM)

41.15M

Flux de Trésorerie d'Investissement (TTM)

-16.02M

Flux de Trésorerie de Financement (TTM)

-45.34M

Flux de Trésorerie Libre (TTM)

41.16M

Dépenses en Capital (TTM)

-

Variation Nette de la Trésorerie (TTM)

-20.22M

Tendances et prévisions des analystes

0

0

0

0

août

Acheter

Conserver

Vendre

Vente forte

Évaluation et prévisions des analystes

3.5

Conserver

Achat fort

Acheter

Conserver

Vendre

Vente forte

Métriques de Valorisation

Valeur Entreprise

$418.34M

Ratio P/E (TTM)

19.27

Ratio P/E (FWD)

-

Ratio PEG (TTM)

-

Ratio P/S (TTM)

2.20

Ratio P/B (TTM)

3.66

Rendement des Bénéfices % (TTM)

5.19%

Rendement des Bénéfices % (FWD)

-

EV / EBITDA (TTM)

9.26

Prix / EBITDA (TTM)

11.27

Prix / Flux de Trésorerie Libre (TTM)

12.37

Valeur Comptable / Action

$2.68

Dette Entreprise

Dette Totale

-

Dette à Long Terme

-

Émission de Dette à Long Terme (TTM)

-

Remboursement de la Dette à Long Terme (TTM)

-$44.45M

Trésorerie Totale

$36.54M

Dette sur Capitaux Propres

0.03

Émission de Dette (TTM)

-$44.45M

Remboursement de la Dette (TTM)

-$44.45M